2m 2m 2m 2m 2m 2m 2m
Pacific Bio CA (PACB)
NASDAQ
$1.31+$0.009 (+0.69%)
Price as of Sep 11, 2026 7:37 PM EDT- $404.1MMarket Cap
- 11.11%1-Year Change
- Medical DevicesIndustry
Pacific Bio CA (PACB)
$1.31+$0.009 (+0.69%)
PACB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.30 | ||
Change | +$0.03 (+2.36%) | ||
Open | $1.29 | ||
High | $1.32 | ||
Low | $1.28 | ||
Previous Close | $1.27 | ||
Volume | 3,733,941 | ||
30-Day Average Volume | 6,419,679 | ||
1-Week Change | -3.70% | ||
1-Month Change | 14.04% | ||
1-Year Change | 11.11% | ||
3-Year Change | -87.48% | ||
5-Year Change | -95.64% | ||
Fundamentals | |||
Shares Outstanding | 310.8M | ||
Total Assets | $751.9M | ||
Market Cap | $404.1M | ||
Enterprise Value | $987.4M | ||
Period: QTR TTM FY | |||
Revenue | $33.0M | ||
Net Income | -$44.7M | ||
Free Cash Flow | -$37.1M | ||
EBIT | -$42.9M | ||
EBITDA | -$39.4M | ||
Net Working Capital | $269.8M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | 30 | ||
P/B | -12 | ||
P/E | -9 | ||
PEG | 0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue